Literature DB >> 2127279

Prolactin, thymulin and zinc in chronic hemodialysis: effect of renal transplant.

E Togni1, P Travaglini, C Beretta, L Berardinelli, A Vegeto, E Mocchegiani, N Fabris, F Egidi, C Ponticelli, G Faglia.   

Abstract

The interrelationships between PRL, thymulin and Zn, were studied in 25 patients with chronic renal failure (CRF) undergoing kidney transplantation and immunosuppressed with cyclosporine A (CsA). The possible role of serum PRL levels in predicting allograft rejection was also investigated. Before the kidney transplant serum PRL levels were significantly higher than in normals (mean +/- SE, 28.3 +/- 7.1 vs 7.5 +/- 0.6 micrograms/l, p less than 0.001) and their response to TRH (200 micrograms iv) was impaired (mean delta % at peak, 45.4 +/- 9.5 vs + 641 +/- 47.5, p less than 0.001). After kidney transplantation a dramatic decrease in serum PRL concentrations was observed in all patients, followed by a slight upward trend in the following two weeks, while TRH test administered on 3rd, 7th and 14th day, induced a progressive increase in serum PRL responses (delta % at peak, 201 +/- 43.3, 220 +/- 37.1 and 305 +/- 15.5, respectively). No difference in serum PRL patterns was observed between patients with (8 cases) and without (17 cases) clinical features and kidney fine needle biopsies suggestive of rejection. Basal serum Zn levels of patients with CRF (18.1 +/- 0.6 mumol/l) were similar to those observed in normals (17.7 +/- 0.2 mumol/l) and without any correlation with serum PRL levels. A decrement in serum Zn was recorded during CsA infusion and on the first day after the surgery, followed by a slight and slow upward trend. Basal serum thymulin titers were low [2.92 +/- 0.18 (1/log2)], were further reduced after CsA infusion [1.68 +/- 0.15 (1/log2)] and returned to the pretransplant levels in the two weeks after grafting.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2127279     DOI: 10.1007/BF03349606

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  27 in total

1.  Effect of oral zinc administration on prolactin and thymulin circulating levels in patients with chronic renal failure.

Authors:  P Travaglini; P Moriondo; E Togni; P Venegoni; D Bochicchio; A Conti; G Ambroso; C Ponticelli; E Mocchegiani; N Fabris
Journal:  J Clin Endocrinol Metab       Date:  1989-01       Impact factor: 5.958

2.  Immunodeficiency in hypophysectomized rats.

Authors:  E Nagy; I Berczi
Journal:  Acta Endocrinol (Copenh)       Date:  1978-11

3.  Endocrine abnormalities in patients undergoing long-term hemodialysis. The role of prolactin.

Authors:  F Gómez; R de la Cueva; J P Wauters; T Lemarchand-Béraud
Journal:  Am J Med       Date:  1980-04       Impact factor: 4.965

4.  Is zinc status a problem in the dietary treatment of chronic renal failure?

Authors:  P Gilli; F Fagioli; E De Paoli Vitali; A Farinelli
Journal:  Nephron       Date:  1985       Impact factor: 2.847

5.  Monitoring of organ allograft rejection by transplant aspiration cytology.

Authors:  P Häyry; E von Willebrand; J Ahonen; B Eklund; I Lautenschlager
Journal:  Ann Clin Res       Date:  1981

6.  Neuroendocrine control of thymic hormonal production. I. Prolactin stimulates in vivo and in vitro the production of thymulin by human and murine thymic epithelial cells.

Authors:  M Dardenne; W Savino; M C Gagnerault; T Itoh; J F Bach
Journal:  Endocrinology       Date:  1989-07       Impact factor: 4.736

7.  Immunomodulation in rats by transplantable anterior pituitary tumors.

Authors:  E Nagy; H G Friesen; A H Sehon; I Berczi
Journal:  Endocrinology       Date:  1985-03       Impact factor: 4.736

8.  Rapid elevation of rat serum prolactin concentration by cyclosporine, a novel immunosuppressive drug.

Authors:  S B Cardon; D F Larson; D H Russell
Journal:  Biochem Biophys Res Commun       Date:  1984-04-30       Impact factor: 3.575

9.  Divalent cation inhibition of hormone release from isolated adenohypophysial secretory granules.

Authors:  M Y Lorenson; D L Robson; L S Jacobs
Journal:  J Biol Chem       Date:  1983-07-25       Impact factor: 5.157

10.  T cells in patients undergoing chronic hemodialysis: mitogenic response, suppressor activity, and interleukin-2 production and receptor generation.

Authors:  J Raskova; I Ghobrial; S M Shea; E C Ebert; R P Eisinger; K Raska
Journal:  Diagn Immunol       Date:  1986
View more
  2 in total

1.  Total body zinc depletion and its relationship to the development of hyperprolactinemia in chronic renal insufficiency.

Authors:  O Caticha; D Y Norato; M A Tambascia; A Santana; A Stephanou; N J Sarlis
Journal:  J Endocrinol Invest       Date:  1996 Jul-Aug       Impact factor: 4.256

Review 2.  Trace elements in hemodialysis patients: a systematic review and meta-analysis.

Authors:  Marcello Tonelli; Natasha Wiebe; Brenda Hemmelgarn; Scott Klarenbach; Catherine Field; Braden Manns; Ravi Thadhani; John Gill
Journal:  BMC Med       Date:  2009-05-19       Impact factor: 8.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.